West Roxbury, MA, United States of America

Ajit Bharti

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ajit Bharti: Innovator in Cancer Therapy

Introduction

Ajit Bharti is a notable inventor based in West Roxbury, MA (US). He has made significant contributions to the fields of cancer therapy and prevention through his innovative research and patented inventions. With a total of 4 patents, his work focuses on improving the efficacy of cancer treatments.

Latest Patents

One of Ajit Bharti's latest patents is centered around BRCA1 mutations as predictive markers for topoisomerase inhibitions. This invention relates to a diagnostic marker that predicts the effectiveness of topoisomerase I (topo I) inhibitors in cancer treatment. The patent outlines methods, machines, computer systems, and kits designed to identify and assess the sensitivity or resistance of tumor cells to topo I inhibitors, such as camptothecin and its analogues. Additionally, it addresses the identification of mutations in the BRCA1 gene that may indicate a patient's responsiveness to these inhibitors. Another aspect of his work involves the use of plant extracts and compounds for treating various diseases, including cancer.

Career Highlights

Ajit Bharti has worked with reputable organizations, including the Boston Medical Center Corporation. His career reflects a commitment to advancing cancer treatment methodologies through innovative research and development.

Collaborations

Throughout his career, Ajit has collaborated with professionals such as Vipul C Chitalia and Daniel Prabakaran, contributing to a rich exchange of ideas and advancements in the field.

Conclusion

Ajit Bharti's contributions to cancer therapy through his patents and collaborations highlight his role as a significant innovator in the medical field. His work continues to pave the way for improved treatment options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…